TW585910B - Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins - Google Patents

Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins Download PDF

Info

Publication number
TW585910B
TW585910B TW088102005A TW88102005A TW585910B TW 585910 B TW585910 B TW 585910B TW 088102005 A TW088102005 A TW 088102005A TW 88102005 A TW88102005 A TW 88102005A TW 585910 B TW585910 B TW 585910B
Authority
TW
Taiwan
Prior art keywords
ala
leu
val
gly
ave
Prior art date
Application number
TW088102005A
Other languages
English (en)
Chinese (zh)
Inventor
Kim Jonelle Stutzman-Engwall
Yoshihiro Katoh
Hamish Alastair Irivi Mcarthur
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of TW585910B publication Critical patent/TW585910B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW088102005A 1998-02-13 1999-02-09 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins TW585910B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7463698P 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
TW585910B true TW585910B (en) 2004-05-01

Family

ID=22120706

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088102005A TW585910B (en) 1998-02-13 1999-02-09 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins

Country Status (32)

Country Link
EP (1) EP1053335A1 (fr)
JP (2) JP2002503473A (fr)
KR (3) KR100499214B1 (fr)
CN (2) CN1521180A (fr)
AP (1) AP9901463A0 (fr)
AR (1) AR018085A1 (fr)
AU (1) AU752343C (fr)
BG (1) BG64911B1 (fr)
BR (1) BR9907893A (fr)
CA (2) CA2320031A1 (fr)
CO (1) CO5070698A1 (fr)
DZ (1) DZ2720A1 (fr)
EA (1) EA003905B1 (fr)
GT (1) GT199900014A (fr)
HN (1) HN1999000008A (fr)
HR (1) HRP20000539A2 (fr)
HU (1) HUP0100784A3 (fr)
IL (2) IL137610A0 (fr)
IS (1) IS5567A (fr)
MA (1) MA24760A1 (fr)
NO (1) NO20004044L (fr)
NZ (2) NZ518657A (fr)
OA (1) OA11449A (fr)
PA (1) PA8467601A1 (fr)
PE (1) PE20000352A1 (fr)
PL (1) PL194270B1 (fr)
SK (1) SK11722000A3 (fr)
TN (1) TNSN99017A1 (fr)
TW (1) TW585910B (fr)
WO (1) WO1999041389A1 (fr)
YU (1) YU50900A (fr)
ZA (1) ZA991138B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100499214B1 (ko) * 1998-02-13 2005-07-07 화이자 프로덕츠 인코포레이티드 아베르멕틴의 b2:b1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
AU778837B2 (en) 1999-08-12 2004-12-23 Zoetis Services Llc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
IL162866A0 (en) 2002-02-12 2005-11-20 Pfizer Prod Inc Streptomyces a vermitilis gene directing the ratioof b2:b1 avermectins
CN107338210B (zh) * 2017-09-05 2021-08-17 天津科技大学 一种阿维链霉菌合成培养基及其发酵液的制备方法
CN111269296B (zh) * 2020-03-06 2021-11-05 山东大学 一种nLsA蛋白及其结构基因和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (fr) * 1987-01-23 1991-01-19 Pfizer
ES2054822T3 (es) * 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.
JPH0747171B2 (ja) * 1988-09-20 1995-05-24 株式会社東芝 圧延機の設定方法および装置
EP0391594B1 (fr) * 1989-03-31 1995-10-18 Merck & Co. Inc. Clonage de gènes de Streptomyces avermitilis pour la biosynthèse de l'avermectine et procédés pour leur utilisation
US5252474A (en) * 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法
FI942725A (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
KR100499214B1 (ko) * 1998-02-13 2005-07-07 화이자 프로덕츠 인코포레이티드 아베르멕틴의 b2:b1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자

Also Published As

Publication number Publication date
IL183596A0 (fr) 2007-09-20
IS5567A (is) 2000-07-20
AP9901463A0 (en) 1999-03-31
BG104759A (en) 2001-04-30
KR20040053390A (ko) 2004-06-23
OA11449A (en) 2003-12-03
PL342468A1 (en) 2001-06-04
NO20004044L (no) 2000-10-11
BG64911B1 (bg) 2006-08-31
EP1053335A1 (fr) 2000-11-22
CA2521289A1 (fr) 1999-08-19
HRP20000539A2 (en) 2001-04-30
AU1887899A (en) 1999-08-30
AR018085A1 (es) 2001-10-31
GT199900014A (es) 2000-07-25
KR20040099389A (ko) 2004-11-26
AU752343B2 (en) 2002-09-19
TNSN99017A1 (fr) 2005-11-10
WO1999041389A1 (fr) 1999-08-19
EA200000758A1 (ru) 2001-04-23
AU752343C (en) 2005-11-03
HUP0100784A3 (en) 2004-10-28
NO20004044D0 (no) 2000-08-11
MA24760A1 (fr) 1999-10-01
HN1999000008A (es) 1999-10-29
JP2002503473A (ja) 2002-02-05
JP4011036B2 (ja) 2007-11-21
PE20000352A1 (es) 2000-05-16
KR100499214B1 (ko) 2005-07-07
DZ2720A1 (fr) 2003-09-01
PL194270B1 (pl) 2007-05-31
IL137610A0 (en) 2001-07-24
EA003905B1 (ru) 2003-10-30
CO5070698A1 (es) 2001-08-28
HUP0100784A2 (hu) 2001-06-28
KR20010052166A (ko) 2001-06-25
ZA991138B (en) 2000-08-14
YU50900A (sh) 2004-03-12
SK11722000A3 (sk) 2001-04-09
PA8467601A1 (es) 2000-09-29
BR9907893A (pt) 2000-11-14
NZ505676A (en) 2003-02-28
JP2004283174A (ja) 2004-10-14
CA2320031A1 (fr) 1999-08-19
CN1521180A (zh) 2004-08-18
CN1297485A (zh) 2001-05-30
NZ518657A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
TW585910B (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
JP2005198658A (ja) B2:B1アベルメクチン比率を支配するStreptomycesavermitilis遺伝子
KR20000023111A (ko) 아베르멕틴 생성을 증가시키기 위한 스트렙토마이시즈아베르미틸리스 조절 유전자
KR100489856B1 (ko) B2:b1 아베르멕틴의 비율을 제어하는 스트렙토마이세스아베르미틸리스 유전자
US6733998B1 (en) Micromonospora echinospora genes coding for biosynthesis of calicheamicin and self-resistance thereto
KR100718378B1 (ko) B2:b1 아베르멕틴의 비를 제어하는 스트렙토마이세스아베르미틸리스 유전자
JP2002533067A (ja) カリケアマイシンの生合成とカリケアマイシンに対する自己耐性をコードするミクロモノスポラ・エキノスポラ遺伝子
CZ323299A3 (cs) Regulační geny Streptomyces avermitilis a způsob zvýšené produkce avermektinů
CZ20002794A3 (cs) Gen Streptomyces avermitilis řídící poměr B2:B1 avermektinů
CN105754921A (zh) 一种产5-酮基-22,23-双氢多拉菌素的基因工程菌及其制备方法和应用
MXPA00007915A (en) I(streptomyces avermitilis) gene directing the ratio of b2:b1 avermectins